Eighth Circuit Hears Novartis Case Against Missouri Pharmacy Law

A federal appeals court panel on Thursday heard Novartis AG‘s renewed arguments seeking a preliminary injunction against a Missouri law that requires it to discount drugs to an unlimited number of pharmacies under a federal discount drug pricing program.

The case is before the US Court of Appeals for the Eighth Circuit after the drugmaker failed to show it would suffer harm under Missouri’s law (SB 751) in the US District Court for the Western District of Missouri in February 2025, or that it was likely to win its constitutional challenge against the law on its merits, ...